Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

What is the Expected Growth Rate of the Anti-Neoplastic Agents Market from 2024 to 2033?

The anti-neoplastic agents market has expanded significantly in recent years. It is expected to grow from $118.03 billion in 2023 to $130.01 billion in 2024, reflecting a compound annual growth rate (CAGR) of 10.1%. The market’s growth during the historical period is driven by the increasing incidence of cancer, growing demand for therapies, and the rising preference for minimally invasive cancer treatments, alongside a push for affordable anti-neoplastic treatments.

The anti-neoplastic agents market is expected to grow significantly, reaching $184.17 billion by 2028, with a CAGR of 9.1%. This growth is driven by increased patient education and awareness, government initiatives, the rising demand for personalized cancer treatments, and a focus on quality of life in cancer treatment. Key trends include advancements in oncology research, targeted therapies, biotechnology innovations, and improved diagnostic tools.

Claim Your Free Sample of the Global Anti-Neoplastic Agents Market Report Today!

https://www.thebusinessresearchcompany.com/sample.aspx?id=12901&type=smp

The rising number of cancer cases is expected to fuel the expansion of the antineoplastic agent market. Cancer, a disease where abnormal cells grow uncontrollably and spread, is treated with antineoplastic agents that block cancer cell growth. According to the American Cancer Society, 1.9 million new cancer cases are projected in the U.S. in 2023, up from 1.8 million in 2020, with 609,820 cancer-related deaths anticipated in 2023. This surge in cancer cases is a major driver for the antineoplastic agent market’s growth.

1) By Type: Alkylating Agents, Antimetabolites, Hormones And Antagonists, Miscellaneous

2) By Disease Type: Gastrointestinal Cancer, Prostate Cancer, Lung Cancer, Breast Cancer, Other Disease Types

3) By End User: Hospitals, Clinics, Cancer Rehabilitation Centers, Ambulatory Surgical Centers

Companies in the anti-neoplastic agent market are focusing on developing clinical practices to enhance their market presence. For instance, in March 2022, Novartis AG received FDA approval for Pluvicto, a radioligand therapy for metastatic castration-resistant prostate cancer (mCRPC). Pluvicto is administered intravenously every six weeks for up to six doses. The therapy targets PSMA expression in tumors, and mCRPC patients who have already undergone treatment are selected for Pluvicto therapy using authorized imaging agents.

Order Now for Fast Delivery of Your Anti-Neoplastic Agents Market Report!

https://www.thebusinessresearchcompany.com/report/anti-neoplastic-agents-global-market-report

North America was the largest region in the automotive constant velocity joint market in 2023. The regions covered in the automotive constant velocity joint market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The Anti-Neoplastic Agents Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the anti-neoplastic agents market, its market share, and analyzes key competitors along with their market positions.

The Table Of Content For The Anti-Neoplastic Agents Market Include

1. Anti-Neoplastic Agents Market Executive Summary

2. Anti-Neoplastic Agents Market Segments

3. Anti-Neoplastic Agents Market Size And Template Market Growth Rate

4. Key Anti-Neoplastic Agents Market Trends

5. Major Anti-Neoplastic Agents Market Drivers

……

25. Key Mergers And Acquisitions In The Anti-Neoplastic Agents Market

26. Top Anti-Neoplastic Agents Companies

27. Anti-Neoplastic Agents Market Opportunities And Strategies

28. Anti-Neoplastic Agents Market, Conclusions And Recommendations

29. Appendix

Discover Related Reports by The Business Research Company:

Tissue Microarray Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/tissue-microarray-global-market-report

Soft Tissue Sarcoma Opportunities Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/soft-tissue-sarcoma-global-market-report

Tissue Engineering Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/tissue-engineering-global-market-report

Learn More About The Business Research Company

The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: